🕵️ OPUS Genetics, Inc. ($IRD)
SEC insider & ownership activity, last 12 months · CIK 1228627 · every row links its SEC filing
Over the last 12 months insiders sold $16.5M against $324K of open-market buying. Foundation Fighting Blindness Retinal Degeneration Fund sold $16.0M in discretionary trades (Dec–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $324K (2 lots) · 7 sellers, $16.5M (16 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | 0 | – | 2 | $16.0M | May 18, 2026 |
| Gallagher Cam | 2 | $324K | 0 | – | Dec 29, 2025 |
| Magrath George | 0 | – | 3 | $205K | Jul 23, 2026 |
| Robert E. Gagnon | 0 | – | 2 | $64K | Jul 23, 2026 |
| Benjamin R. Yerxa | 0 | – | 2 | $61K | Jul 23, 2026 |
| Jayagopal Ashwath | 0 | – | 2 | $58K | Apr 23, 2026 |
| Joseph K. Schachle | 0 | – | 3 | $58K | Jul 23, 2026 |
| Zaremba Rabourn Amy | 0 | – | 2 | $23K | Apr 23, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Foundation Fight Blindness, Inc. | 15.9% | 13D | Apr 30, 2025 | filing ↗ | |
| Perceptive Advisors LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Joseph Edelman | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Caligan Partners LP | 8.5% | 13G | May 15, 2026 | filing ↗ | |
| Johnson David Edward | 8.5% | 13G | May 15, 2026 | filing ↗ | |
| Adage Capital Management, L.P. | 8.5% | 13G | May 13, 2026 | filing ↗ | |
| Robert Atchinson | 8.5% | 13G | May 13, 2026 | filing ↗ | |
| Phillip Gross | 8.5% | 13G | May 13, 2026 | filing ↗ | |
| Balyasny Asset Management L.P. | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| BAM GP LLC | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Balyasny Asset Management Holdings LP | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Dames GP LLC | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Dmitry Balyasny | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Leslie Wayne Kreis, JR. | 6.2% | 13G | Aug 11, 2025 | filing ↗ | |
| Aaron Glenn Louis Fletcher | 6.2% | 13G | Aug 11, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert E. Gagnon | $24K | Jul 23, 2026 | filing ↗ |
| Magrath George | $29K | Jul 23, 2026 | filing ↗ |
| Joseph K. Schachle | $14K | Jul 23, 2026 | filing ↗ |
| Benjamin R. Yerxa | $22K | Jul 23, 2026 | filing ↗ |
| Joseph K. Schachle | $25K | Apr 23, 2026 | filing ↗ |
| Benjamin R. Yerxa | $39K | Apr 23, 2026 | filing ↗ |
| Magrath George | $127K | Apr 23, 2026 | filing ↗ |
| Robert E. Gagnon | $41K | Apr 23, 2026 | filing ↗ |
| Jayagopal Ashwath | $39K | Apr 23, 2026 | filing ↗ |
| Magrath George | $127K | Mar 16, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 20, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 2, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 13, 2026 | filing ↗ |
| Earnings (2.02) | Feb 13, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 13, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 13, 2026 | filing ↗ |
| Other events (8.01) | Feb 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Dec 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 6, 2025 | filing ↗ |